ALGN logo

Align Technology Inc. (ALGN)

$163.46

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ALGN

Market cap

$11.52B

EPS

6.86

P/E ratio

24.8

Price to sales

2.45

Dividend yield

--

Beta

1.73467

Price on ALGN

Previous close

$165.98

Today's open

$165.46

Day's range

$162.17 - $167

52 week range

$130.23 - $200.44

Profile about ALGN

CEO

Joseph M. Hogan

Employees

20290

Headquarters

Tempe, AZ

Exchange

Nasdaq Global Select

Shares outstanding

70487053

Issue type

Common Stock

ALGN industries and sectors

Healthcare

Medical Equipment & Supplies

News on ALGN

Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • 20 hours ago

news preview

Should You Continue to Hold ALGN Stock in Your Portfolio?

Align Technology's Invisalign expansion, strategic alliances and strong stock gains support its prospects, but currency volatility and competition pose risks.

news source

Zacks Investment Research • 21 hours ago

news preview

Align Technology to Speak at Upcoming Financial Conference

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at ht.

news source

Business Wire • Nov 10, 2026

news preview

Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”), to repurchase $270 million of Align's common s.

news source

Business Wire • Nov 6, 2026

news preview

Align Technology Recognized in Extel's 2026 All-America Executive Team Rankings

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced recognition in the 2026 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qual.

news source

Business Wire • Nov 6, 2026

news preview

Align Technology: Q3 Results Expose Weak Pricing Power Amidst Declining Market Share

Align Technology remains the global leader in clear aligners but faces intensifying competition and declining pricing power, especially in North America. ALGN's US market is saturated, with falling shipments, utilization, and revenue per case; international growth is now the primary driver. Gross margins and brand strength are under pressure, with competitors gaining share through lower costs and improved aesthetics.

news source

Seeking Alpha • Nov 2, 2026

news preview

Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2027 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to un.

news source

Business Wire • Nov 2, 2026

news preview

Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern

Align Technology faces new catalysts, developments, and litigation progress that shift the investment landscape. Market sentiment currently appears to emphasize the risks associated with ALGN over potential opportunities. I now favor an intrinsic valuation approach based on future cash flows rather than relying solely on multiples or peer averages.

news source

Seeking Alpha • Oct 30, 2026

news preview

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls

Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.

news source

Zacks Investment Research • Oct 29, 2026

news preview

Align Technology Q3 Earnings Call Highlights

Align Technology NASDAQ: ALGN reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued pressure in discretionary dental spending and capital-equipment purchasing.

news source

MarketBeat • Oct 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Align Technology Inc.

Open an M1 investment account to buy and sell Align Technology Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ALGN on M1